CMLS III Stockholder Settlement
Last verified September 18, 2026Source: jndHow ClaimWatch verifies cases
This settlement is closed to new claims — the deadline was May 25, 2026. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →
What happened
Plaintiffs alleged that the defendants breached fiduciary duties in connection with stockholder matters related to CM Life Sciences III, Inc. The defendants deny all wrongdoing, but have agreed to settle the class action lawsuit for $7,250,000.
Do you qualify?
All record and beneficial holders of CM Life Sciences III, Inc. (CMLS III) Class A Common Stock who held such stock immediately following the Redemption Deadline of 5:00 PM ET on December 14, 2021, including their successors in interest who obtained shares by operation of law. Excluded are the defendants, their immediate families, entities with controlling interests held by them, and their representatives, heirs, or assignees.
What you can claim
Read from the official settlement notice. Confirm the terms that apply to you on the administrator's site before filing.
Settlement distribution
Eligible Class Members who submit a Proof of Claim and Release may receive a distribution from the Settlement proceeds, paid directly to them.
Who is in the class
All record and beneficial holders of CM Life Sciences III, Inc. ("CMLS III") Class A Common Stock who held such stock immediately following the Redemption Deadline of 5:00 PM ET on December 14, 2021, including their successors in interest who obtained shares by operation of law.
Quoted from the settlement notice.
How to file
Class members must submit a Proof of Claim and Release by May 25, 2026 to be eligible for a distribution from the settlement proceeds. The Proof of Claim can be obtained and submitted through the settlement website or by contacting the Settlement Administrator at 1-877-206-2312 or info@CMLSiiiStockholderSettlement.com.
Common questions
- How much does the CMLS III Stockholder Settlement pay?
- The total settlement fund is $7.3M. Actual amounts depend on how many valid claims are filed — most settlements divide a fixed fund pro rata, so a higher claim rate means a smaller individual check. An "up to" figure is a cap, not a guarantee.
- What is the claim deadline for the CMLS III Stockholder Settlement?
- This settlement is closed to new claims — the deadline was May 25, 2026. Once a claim deadline passes you generally forfeit your share, even if you qualified.
- Do I need proof of purchase for the CMLS III Stockholder Settlement?
- Yes. This settlement asks for documentation supporting your claim — a receipt, an account record, or the notice you were sent. Check the official settlement website for exactly which documents are accepted.
- Is the CMLS III Stockholder Settlement notice real, or a scam?
- JND Legal Administration is the settlement administrator for this case. Claims are filed at cmlsiiistockholdersettlement.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
- When will payments from the CMLS III Stockholder Settlement be sent?
- Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for April 21, 2026; no payments can be issued before a settlement receives final approval.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More securities settlements
View all →Eagle Pharma Securities Litigation Settlement
Eagle Pharmaceuticals, Inc. is the subject of a securities litigation class action. Shareholders who purchased the company's publicly traded common stock between August 9, 2022 and October 1, 2024 allege claims covered by this settlement, which the defendant has agreed to settle.
…moreHut 8 Corp. Securities Class Action Settlement
Hut 8 Corp. and individual defendants are accused of alleged securities violations. The company and defendants have agreed to settle claims from investors who purchased securities during the class period without admitting wrongdoing.
Kornit Digital Ltd. Securities Litigation Settlement
Kornit Digital Ltd. and its executives are accused of securities fraud in this class action lawsuit. The defendants have denied all claims and admit no wrongdoing, but have agreed to settle the case for $19.5 million to eliminate the burden and expense of continued litigation.
…more